{"schema_version":"1","generated_at":"2026-11-21T18:34:47.097Z","data_as_of":null,"url":"https://www.findmykol.com/kol/joan-kramer","json_url":"https://www.findmykol.com/kol/joan-kramer/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"joan-kramer","name":"Joan Kramer","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Emory University","institution_url":"https://www.findmykol.com/institution/emory-university","city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Joan Kramer is an Oncology physician affiliated with Emory University. OpenAlex indexes 22 publications with 21,401 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":22,"cited_by_count":21401,"h_index":15,"latest_activity_year":2023,"citation_standing":{"top_percent":10,"cohort":"Hematology / Oncology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01065675","title":"Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)","phase":"NA","status":"TERMINATED","role":"Overall official","sponsor":"Wesley Medical Center","source_url":"https://clinicaltrials.gov/study/NCT01065675","trial_url":"https://www.findmykol.com/trial/NCT01065675"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Novartis","program_year":2023,"amount_usd":135503.75,"payment_count":2},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2023,"amount_usd":18.6,"payment_count":1},{"payer":"Novartis","program_year":2022,"amount_usd":525408.47,"payment_count":2}],"source":"payments"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":100,"drugs":[{"name":"Oxycodone Hcl","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"facility","data_year":2022,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":22,"shown":5,"withheld":17,"matched_by":"OpenAlex author record","recent":[{"title":"Cancer treatment and survivorship statistics, 2022","year":2022,"journal":"CA A Cancer Journal for Clinicians","source_url":"https://doi.org/10.3322/caac.21731","status":"verified"},{"title":"Breast Cancer Statistics, 2022","year":2022,"journal":"CA A Cancer Journal for Clinicians","source_url":"https://doi.org/10.3322/caac.21754","status":"verified"},{"title":"Gemcitabine with carboplatin in metastatic breast cancer: Characterizing outcomes in a modern, real-world population.","year":2020,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e13085","status":"verified"},{"title":"Cancer treatment and survivorship statistics, 2019","year":2019,"journal":"CA A Cancer Journal for Clinicians","source_url":"https://doi.org/10.3322/caac.21565","status":"verified"},{"title":"The burden of rare cancers in the United States","year":2017,"journal":"CA A Cancer Journal for Clinicians","source_url":"https://doi.org/10.3322/caac.21400","status":"verified"}],"source":"works"},"similar":[{"name":"Allan Levey","slug":"allan-levey","institution":"Emory University","specialty":"Neurology","url":"https://www.findmykol.com/kol/allan-levey","json_url":"https://www.findmykol.com/kol/allan-levey/profile.json"},{"name":"Craig Coopersmith","slug":"craig-coopersmith","institution":"Emory University","specialty":"Critical Care Medicine","url":"https://www.findmykol.com/kol/craig-coopersmith","json_url":"https://www.findmykol.com/kol/craig-coopersmith/profile.json"},{"name":"James Lah","slug":"james-lah","institution":"Emory University","specialty":"Neurology","url":"https://www.findmykol.com/kol/james-lah","json_url":"https://www.findmykol.com/kol/james-lah/profile.json"},{"name":"Vasilis Babaliaros","slug":"vasilis-babaliaros","institution":"Emory University","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/vasilis-babaliaros","json_url":"https://www.findmykol.com/kol/vasilis-babaliaros/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":17}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}